Currently, the known and available PCa screening tests in Uganda are prostate-specific antigen (PSA) and digital rectal exam (DRE) targeting men aged 40 (the most at-risk individuals, especially men with a family history of PCa) or 50 years and above. Here, KLK3 is linked to posterior cortical atrophy.